AUGUST 2023LIFE SCIENCES REVIEW534MediSpendLAST WORD2024272936Anita Nelsen, Senior Vice President, Clinical Trial Operations, AllucentChris Braithwaite, Svp And Global Head Of Drug Development Technology, NovartisImelda Rillon, Director, Regional Quality Assurance, Zuellig PharmaThomas Gilbert, Ph. D., Vice President, Research & Development, Integra LifesciencesRachel Legmann, Phd, Senior Director Of Technology, Gene Therapy, Repligen CorpKelly H. Zou, Phd, Pstat®, Fasa, Head Of Global Medical Analytics And Real World Evidence, ViatrisPatient-Centric Approach to Accelerating Clinical TrialsCloud Computing Driving Change in Pharma IndustryQuality Assurance: Navigating the Escalating Compliance ComplexitiesGene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and InnovationArtificial Intelligence and the Healthcare IndustryIN MY OPINION08Advanced Tissue Technologies Maximize Flexibility in Regenerative MedicineEnsuring Safe Drug Development with Regulatory ComplianceEnrique Blanco, Director Of Operations, Grupo Loeffler-Russek38CXO INSIGHTSLIFE SCIENCECOMPLIANCETOP 10SOLUTIONS PROVIDERS - 2023Featured Company
< Page 4 | Page 6 >